메뉴 건너뛰기




Volumn 5, Issue , 2015, Pages

Tumor cell secretion of soluble factor(s) for specific immunosuppression

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

EID: 84924359571     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08913     Document Type: Article
Times cited : (59)

References (41)
  • 1
    • 84960949820 scopus 로고
    • Cancer - A Biological Approach. 3. Viruses Associated with Neoplastic Conditions
    • Burnet, M. Cancer - a Biological Approach. 3. Viruses Associated with Neoplastic Conditions. Brit Med J 1, 841-846 (1957).
    • (1957) Brit Med J , vol.1 , pp. 841-846
    • Burnet, M.1
  • 3
    • 0035320526 scopus 로고    scopus 로고
    • A fresh look at tumor immunosurveillance and immunotherapy
    • Smyth, M., Godfrey, D. & Trapani, J. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2, 293-299 (2001).
    • (2001) Nat Immunol , vol.2 , pp. 293-299
    • Smyth, M.1    Godfrey, D.2    Trapani, J.3
  • 4
    • 84884252997 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells in cancer: Recent progress and prospects
    • Khaled, Y., Ammori, B. & Elkord, E. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol 91, 493-502 (2013).
    • (2013) Immunol Cell Biol , vol.91 , pp. 493-502
    • Khaled, Y.1    Ammori, B.2    Elkord, E.3
  • 5
    • 44349150012 scopus 로고    scopus 로고
    • Inhibitory B7-family molecules in the tumor microenvironment
    • Zou, W. & Chen, L. Inhibitory B7-family molecules in the tumor microenvironment. Nat Rev Immunol 8, 467-477 (2008).
    • (2008) Nat Rev Immunol , vol.8 , pp. 467-477
    • Zou, W.1    Chen, L.2
  • 6
    • 40849086381 scopus 로고    scopus 로고
    • Immunoregulatory T cells: Role and potential as a target in malignancy
    • Beyer, M. & Schultze, J. Immunoregulatory T cells: role and potential as a target in malignancy. Curr Oncol Rep 10, 130-136 (2008).
    • (2008) Curr Oncol Rep , vol.10 , pp. 130-136
    • Beyer, M.1    Schultze, J.2
  • 7
    • 33751536158 scopus 로고    scopus 로고
    • Immune selective pressure and HLA class I antigen defects in malignant lesions
    • Chang, C.-C. & Ferrone, S. Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immun 56, 227-236 (2007).
    • (2007) Cancer Immunol Immun , vol.56 , pp. 227-236
    • Chang, C.-C.1    Ferrone, S.2
  • 8
    • 0036852191 scopus 로고    scopus 로고
    • Natural selection of tumor variants in the generation of "tumor escape" phenotypes
    • Khong, H. & Restifo, N. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 3, 999-1005 (2002).
    • (2002) Nat Immunol , vol.3 , pp. 999-1005
    • Khong, H.1    Restifo, N.2
  • 9
    • 0035865146 scopus 로고    scopus 로고
    • Role of TGF-beta in immune-evasion of cancer
    • Beck, C., Schreiber, H. & Rowley, D. Role of TGF-beta in immune-evasion of cancer. Microsc Res Techniq 52, 387-395 (2001).
    • (2001) Microsc Res Techniq , vol.52 , pp. 387-395
    • Beck, C.1    Schreiber, H.2    Rowley, D.3
  • 10
    • 0031932868 scopus 로고    scopus 로고
    • Immune evasion by tumors: Involvement of the CD95 (APO-1/Fas) system and its clinical implications
    • Strand, S.&Galle, P. Immune evasion by tumors: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol Med Today 4, 63-68 (1998).
    • (1998) Mol Med Today , vol.4 , pp. 63-68
    • Strand, S.1    Galle, P.2
  • 11
    • 0036852241 scopus 로고    scopus 로고
    • Cancer immunoediting: From immunosurveillance to tumor escape
    • Dunn, G., Bruce, A., Ikeda, H., Old, L. & Schreiber, R. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3, 991-998 (2002).
    • (2002) Nat Immunol , vol.3 , pp. 991-998
    • Dunn, G.1    Bruce, A.2    Ikeda, H.3    Old, L.4    Schreiber, R.5
  • 12
    • 0026503190 scopus 로고
    • Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor
    • Aslakson, C. & Miller, F. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52, 1399-1405 (1992).
    • (1992) Cancer Res , vol.52 , pp. 1399-1405
    • Aslakson, C.1    Miller, F.2
  • 13
    • 0023633109 scopus 로고
    • Analysis of tumor cell composition in tumors composed of paired mixtures of mammary tumor cell lines
    • Miller, B., Miller, F., Wilburn, D. & Heppner, G. Analysis of tumor cell composition in tumors composed of paired mixtures of mammary tumor cell lines. Brit J Cancer 56, 561-569 (1987).
    • (1987) Brit J Cancer , vol.56 , pp. 561-569
    • Miller, B.1    Miller, F.2    Wilburn, D.3    Heppner, G.4
  • 14
    • 33845944941 scopus 로고    scopus 로고
    • Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factors
    • DuPre, S. & Hunter, K. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 82, 12-24 (2007).
    • (2007) Exp Mol Pathol , vol.82 , pp. 12-24
    • DuPre, S.1    Hunter, K.2
  • 15
    • 67349133537 scopus 로고    scopus 로고
    • Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
    • Le, H. et al. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int immunopharmacol 9, 900-909 (2009).
    • (2009) Int Immunopharmacol , vol.9 , pp. 900-909
    • Le, H.1
  • 16
    • 61349100687 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells as regulators of the immune system
    • Gabrilovich,D. &Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162-174 (2009).
    • (2009) Nat Rev Immunol , vol.9 , pp. 162-174
    • Gabrilovich, D.1    Nagaraj, S.2
  • 17
    • 35448954376 scopus 로고    scopus 로고
    • Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
    • Bunt, S. K. et al. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67, 10019-10026 (2007).
    • (2007) Cancer Res , vol.67 , pp. 10019-10026
    • Bunt, S.K.1
  • 18
    • 4143141823 scopus 로고    scopus 로고
    • The immunobiology of cancer immunosurveillance and immunoediting
    • Dunn, G., Old, L. & Schreiber, R. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148 (2004).
    • (2004) Immunity , vol.21 , pp. 137-148
    • Dunn, G.1    Old, L.2    Schreiber, R.3
  • 19
    • 0027411525 scopus 로고
    • TheMolecular Cell Biology of Interferon-gamma and its Receptor
    • Farrar, M. A. & Schreiber, R. D. TheMolecular Cell Biology of Interferon-gamma and its Receptor. Annual Review of Immunol 11, 571-611 (1993).
    • (1993) Annual Review of Immunol , vol.11 , pp. 571-611
    • Farrar, M.A.1    Schreiber, R.D.2
  • 20
    • 0036681991 scopus 로고    scopus 로고
    • Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma
    • Pulaski, B., Smyth, M. & Ostrand-Rosenberg, S. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Cancer Res 62, 4406-4412 (2002).
    • (2002) Cancer Res , vol.62 , pp. 4406-4412
    • Pulaski, B.1    Smyth, M.2    Ostrand-Rosenberg, S.3
  • 21
    • 1642279609 scopus 로고    scopus 로고
    • Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms
    • Shi, X., Cao, S., Mitsuhashi, M., Xiang, Z. & Ma, X. Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms. J Immunol 172, 4111-4122 (2004).
    • (2004) J Immunol , vol.172 , pp. 4111-4122
    • Shi, X.1    Cao, S.2    Mitsuhashi, M.3    Xiang, Z.4    Ma, X.5
  • 22
    • 55149111143 scopus 로고    scopus 로고
    • Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation
    • Maynard, C. & Weaver, C. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev 226, 219-233 (2008).
    • (2008) Immunol Rev , vol.226 , pp. 219-233
    • Maynard, C.1    Weaver, C.2
  • 23
    • 0032868805 scopus 로고    scopus 로고
    • Effects of TGF-beta on the immune system: Implications for cancer immunotherapy
    • de Visser, K. & Kast, W. Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia 13, 1188-1199 (1999).
    • (1999) Leukemia , vol.13 , pp. 1188-1199
    • De Visser, K.1    Kast, W.2
  • 24
    • 45549088943 scopus 로고    scopus 로고
    • Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17
    • Nam, J.-S. et al. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 68, 3915-3923 (2008).
    • (2008) Cancer Res , vol.68 , pp. 3915-3923
    • Nam, J.-S.1
  • 25
    • 56649118964 scopus 로고    scopus 로고
    • TGF-beta and regulatory T cell in immunity and autoimmunity
    • Wan, Y. & Flavell, R. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 28, 647-659 (2008).
    • (2008) J Clin Immunol , vol.28 , pp. 647-659
    • Wan, Y.1    Flavell, R.2
  • 26
    • 0021690467 scopus 로고
    • Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F
    • Pircher, R., Lawrence, D. & Jullien, P. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res 44, 5538-5543 (1984).
    • (1984) Cancer Res , vol.44 , pp. 5538-5543
    • Pircher, R.1    Lawrence, D.2    Jullien, P.3
  • 27
    • 36148994693 scopus 로고    scopus 로고
    • The other side of MMPs: Protective roles in tumor progression
    • Martin, M. & Matrisian, L. The other side of MMPs: protective roles in tumor progression. Cancer Metast Rev 26, 717-724 (2007).
    • (2007) Cancer Metast Rev , vol.26 , pp. 717-724
    • Martin, M.1    Matrisian, L.2
  • 28
    • 0032323358 scopus 로고    scopus 로고
    • Prognostic significance of soluble Fas in the serum of patients with bladder cancer
    • Mizutani, Y., Yoshida, O. & Bonavida, B. Prognostic significance of soluble Fas in the serum of patients with bladder cancer. J Urol 160, 571-576 (1998).
    • (1998) J Urol , vol.160 , pp. 571-576
    • Mizutani, Y.1    Yoshida, O.2    Bonavida, B.3
  • 29
    • 0032737486 scopus 로고    scopus 로고
    • Circulating soluble Fas concentration in breast cancer patients
    • Ueno, T., Toi, M. & Tominaga, T. Circulating soluble Fas concentration in breast cancer patients. Clin Cancer Res 5, 3529-3533 (1999).
    • (1999) Clin Cancer Res , vol.5 , pp. 3529-3533
    • Ueno, T.1    Toi, M.2    Tominaga, T.3
  • 30
    • 0033064690 scopus 로고    scopus 로고
    • Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
    • Kimura, M. et al. Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients. Br J Cancer 80, 1648-1651 (1999).
    • (1999) Br J Cancer , vol.80 , pp. 1648-1651
    • Kimura, M.1
  • 31
    • 0031783087 scopus 로고    scopus 로고
    • Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma
    • Jodo, S. et al. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma. Clin Exp Immunol 112, 166-171 (1998).
    • (1998) Clin Exp Immunol , vol.112 , pp. 166-171
    • Jodo, S.1
  • 32
    • 0033822691 scopus 로고    scopus 로고
    • Serum soluble Fas level as a prognostic factor in patients with gynecological malignancies
    • Konno, R., Takano, T., Sato, S.&Yajima, A. Serum soluble Fas level as a prognostic factor in patients with gynecological malignancies. Clin Cancer Res 6, 3576-3580 (2000).
    • (2000) Clin Cancer Res , vol.6 , pp. 3576-3580
    • Konno, R.1    Takano, T.2    Sato, S.3    Yajima, A.4
  • 33
    • 0034034661 scopus 로고    scopus 로고
    • Serum soluble Fas levels in ovarian cancer
    • Hefler, L. et al. Serum soluble Fas levels in ovarian cancer. Obstet Gynecol 96, 65-69 (2000).
    • (2000) Obstet Gynecol , vol.96 , pp. 65-69
    • Hefler, L.1
  • 34
    • 0035571794 scopus 로고    scopus 로고
    • Serum soluble Fas level for detection and staging of prostate cancer
    • Furuya, Y., Fuse, H. &Masai, M. Serum soluble Fas level for detection and staging of prostate cancer. Anticancer Res 21, 3595-3598 (2001).
    • (2001) Anticancer Res , vol.21 , pp. 3595-3598
    • Furuya, Y.1    Fuse, H.2    Masai, M.3
  • 35
    • 0032400862 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
    • Gabrilovich, D. et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92, 4150-4166 (1998).
    • (1998) Blood , vol.92 , pp. 4150-4166
    • Gabrilovich, D.1
  • 36
    • 50549218525 scopus 로고
    • The Limited in Vitro Lifetime ofHuman Diploid Cell Strains
    • Hayflick, L. The Limited in Vitro Lifetime ofHuman Diploid Cell Strains. Exp Cell Res 37, 614-636 (1965).
    • (1965) Exp Cell Res , vol.37 , pp. 614-636
    • Hayflick, L.1
  • 38
    • 81855169964 scopus 로고    scopus 로고
    • Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
    • Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551 (2011).
    • (2011) Nature , vol.479 , pp. 547-551
    • Kang, T.W.1
  • 39
    • 84874192617 scopus 로고    scopus 로고
    • T-helper-1-cell cytokines drive cancer into senescence
    • Braumuller, H. et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494, 361-365 (2013).
    • (2013) Nature , vol.494 , pp. 361-365
    • Braumuller, H.1
  • 40
    • 58849154235 scopus 로고    scopus 로고
    • Senescence-messaging secretome: SMS-ing cellular stress
    • Kuilman, T. & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 9, 81-94 (2009).
    • (2009) Nat Rev Cancer , vol.9 , pp. 81-94
    • Kuilman, T.1    Peeper, D.S.2
  • 41
    • 10744231991 scopus 로고    scopus 로고
    • Endothelial cells require STAT3 for protection against endotoxin-induced inflammation
    • Kano, A. et al. Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med 198, 1517-1525 (2003).
    • (2003) J Exp Med , vol.198 , pp. 1517-1525
    • Kano, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.